Brown biostatisticians lead statistics for national mammography trial

October 2, 2017

PROVIDENCE, R.I. [Brown University] — The ECOG-ACRIN Cancer Research Group and the National Cancer Institute have launched the Tomosynthesis Mammographic Imaging Screening Trial (TMIST), a randomized trial that will enroll 165,000 U.S. women to compare two types of digital mammography for breast cancer screening: tomosynthesis (known as three-dimensional, or 3-D) and conventional (two-dimensional, or 2-D).

Led by Professor Constantine Gatsonis, Brown University’s Center for Statistical Sciencesand the Department of Biostatistics will serve as the hub for handling the massive statistical challenges of the study, starting from its innovative design through to the eventual analysis of the results. READ MORE